As part of the monitoring of projects funded by the Recovery and Resilience Plan (PRR), Pedro Dominguinhos, President of the National Monitoring Commission of the PRR (CNA-PRR), visited Bluepharma’s facilities in Eiras, leader of the CiNTech Mobilising Agenda.
The visit included an extended meeting with representatives of the companies that make up the CiNTech consortium, a strategic initiative focused on developing innovative technologies for complex injectable medicines.
During the meeting, results already achieved were presented, challenges faced were analysed, and future perspectives for PRR-supported investments were discussed.
The CiNTech consortium, led by Bluepharma in partnership with the University of Coimbra and other entities, is developing a €30 million project for complex injectable medicine technologies.
Pedro Dominguinhos praised the consortium’s dynamism and commitment, highlighting the relevance of these projects for strengthening the national economy and promoting a more competitive and innovative industry.
